Codifies certain regulatory provisions regarding controlled dangerous substances and prescription monitoring.

This bill limits initial opioid prescriptions for acute pain to a five-day supply and requires doctors to consult the state's prescription monitoring program before prescribing. It mandates that doctors discuss addiction risks, overdose dangers, and non-opioid treatment options with patients (or parents/guardians for minors) before starting opioid therapy. For chronic pain treatment lasting over three months, the bill requires regular treatment reviews every three months, dependence assessments, and a formal pain management agreement between the doctor and patient. These changes directly affect healthcare providers who prescribe opioids and patients receiving such prescriptions in New Jersey.